Introduction: The aim of this study was to compare the rate resolution and improvement of common co-morbidities: type 2 diabetes mellitus (DM), hypertension (HTN), degenerative joint disease (DJD), obstructive sleep apnea (OSA), gastroesophageal reflux disease (GERD), dyslipidemias (LPD) and asthma after Laparoscopic Sleeve Gastrectomy (LSG) or Laparoscopic Adjustable Gastric Band (LAGB).
Methods: Retrospective chart review of patients who underwent LSG or LAGB at our institution from May 2003 to July 2007. The resolution of co-morbidities was determined via patient-completed questionnaires. The Fisher test was used to calculate the p value
Results: A total of 123 patients (males = 29, females = 94) were reviewed, 49 underwent LSG and 74 had LAGB. For the LSG and LAGB patients, mean pre-operative BMI was 41 and 37 kg/m2, the overall percentage Estimated Weight Loss (%EWL) was 39 and 28% (p-0.0026, CI 0.0393 to 0.1807 ), mean follow up was 12 and 15 months, respectively. The table below summarizes the results.
Conclusions: Although both LSG and LAGB resulted in post-operative improvement or resolution of co-morbidities associated with obesity, when compared to LAGB, LSG showed a statistically significant higher rate of resolution or improvement of DM, HTN, and LPD. There was no significant difference between groups for DJD, GERD, OSA and asthma.
Session: Podium Presentation
Program Number: S110